Sorrento Thera

SRNE NASDAQ
3.700
+0.060
+1.65%
盘前: 3.900 +0.2 +5.41% 07:23 06/19 EDT
开盘
3.640
昨收
3.640
最高
3.740
最低
3.590
成交量
71.73万
成交均量(3M)
224.47万
52周最高
7.55
52周最低
1.800
换手率
0.59%
市值
4.53亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Sorrento Thera SRNE股票价格,Sorrento Thera股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. It is also developing therapeutic products for other indications, including immunology and infectious diseases. Its products in the pipeline include Chimeric Antigen Receptor-T Cell (CAR-T) programs, resiniferatoxin (RTX), and biosimilar/biobetter antibodies clinical development programs. Its pipeline also includes preclinical fully human therapeutic monoclonal antibodies (mAbs), including biosimilars/biobetters, fully human anti-PD-L1 and anti-PD-1 checkpoint inhibitors derived from its G-MAB library platform, antibody drug conjugates (ADCs), bispecific antibodies (BsAbs), as well as CAR-T and Chimeric Antigen Receptor Natural Killer (NK) cells (CAR. NK) for adoptive cellular immunotherapy.
展开 >

最近浏览

名称
价格
涨跌幅